|
CAS No:2649467-58-1
R&D 99% new medicine
|
|
CAS No:2649470-87-9
99% R&D Suzetrigine intermediate
|
|
CAS No:1224945-46-3
tert-butyl (R)-2-(2-bromophenyl)pyrrolidine-1-carboxylate factory suply Sonrotoclax intermediate
|
|
CAS No:1224945-45-2
tert-butyl (S)-2-(2-bromophenyl)pyrrolidine-1-carboxylate factory supply Sonrotoclax intermediate
|
|
CAS No:2137423-86-8
factory supply 98% Camlipixant intermediate
|
|
CAS No:645400-44-8
tert-butyl N-[(1S,3S)-3-aminocyclopentyl]carbamate Factory supply commercial production
|
|
CAS No:2189684-44-2
GS-CA1 factory supply mature process
|
|
CAS No:2283356-12-5
Lenacapavir API Salt Factory supply 99.0%
|
|
CAS No:2189684-58-8
Lenacapavir intermediate factory supply 99%
|
|
CAS No:2375019-85-3
Lenacapavir intermediate 2375019-85-3 99.0%
|
|
CAS No:2375019-75-1
Lenacapavir intermediate factory supply 99.0%
|
|
CAS No:19916-73-5
2-Amino-6-(phenylmethoxy)-9H-purine 6-(Benzyloxy)guanine Entecavir intermediate
|
|
CAS No:110567-21-0
3-Cyclopenten-1-ol,2-[(phenylmethoxy)methyl]-, (1S-trans)- commerical production Entecavir intermediate
|
|
CAS No:1118767-16-0
1118767-16-0 factory manufacturing tBuO-Ste-Glu(AEEA-AEEA-OH)-OtBu
|
|
CAS No:1169630-82-3
Commercial supply factory manufacturing 99.0%
|
|
CAS No:910463-68-2
factory supply commercial production API
|
|
CAS No:1784678-61-0
98% factory supply orforglipron intermediate
|
|
CAS No:1118767-16-0
1118767-16-0 (S)-22-(tert-Butoxycarbonyl)-43,43-dimethyl-10,19,24,41-tetraoxo-3,6,12,15,42-pentaoxa-9,18,23-triazatetratetracontanoic acid tBuO-Ste-Glu(AEEA-AEEA-OH)-OtBu
|
|
CAS No:56069-39-7
Phosphonicacid, [(phenylsulfonyl)methyl]-, diethyl ester (6CI,9CI) factory supply Diethyl(phenylsulfonyl)methanephosphonate
|
|
CAS No:2835443-65-5
ERN;2835443-65-5 Eribulin intermediate Factory supply
|
